<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Enrichment Strategies for Clinical Trials To Support Approval of Human Drugs and Biological Products; Extension of Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Enrichment Strategies for Clinical Trials To Support Approval of Human Drugs and Biological Products; Extension of Comment Period</h1>
    <p class="timestamp">Published: 2013-02-04 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is extending the comment period for the draft guidance for industry entitled "Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products" that appeared in the Federal Register of December 17, 2012 (77 FR 74670). In the document, FDA announced the availability of this draft guidance and explained that the comment period would close on February 15, 2013. The Agency is taking this action to allow interested persons add...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-02293</p>
    <p><strong>Publication Date:</strong> 2013-02-04</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/02/04/2013-02293/draft-guidance-for-industry-on-enrichment-strategies-for-clinical-trials-to-support-approval-of">https://www.federalregister.gov/documents/2013/02/04/2013-02293/draft-guidance-for-industry-on-enrichment-strategies-for-clinical-trials-to-support-approval-of</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-02293</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
